← Open Payments lookup

AMANDA MIXON: Open Payments

NPI 1174795017 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,174 in 18 payments from 9 companies in 2025. Trend: 2023 $91,740 · 2024 $30,052 · 2025 $1,174

Food & beverage: $1,174
CompanyPaymentsAmount
GENZYME CORPORATION6$450
UCB, Inc.4$264
AstraZeneca Pharmaceuticals LP2$141
Amgen Inc.1$76
GlaxoSmithKline, LLC.1$63
E.R. Squibb & Sons, L.L.C.1$56
Janssen Biotech, Inc.1$54
Lilly USA, LLC1$41
Boston Scientific Corporation1$29

Products named: KEVZARA, Bimzelx, TAVNEOS, BENLYSTA, TREMFYA, TALTZ, WaveWriter Alpha Prime 16, SAPHNELO.

Industry payments across CO — which companies pay providers there.